vyxeos liposomal (previously known as vyxeos)
jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemija, mieloidna, akutna - antineoplastična sredstva - vyxeos liposomal indiciran za liječenje odraslih bolesnika s je prvi put dijagnosticiran, terapije povezane s oštrim миелоидными лейкозами (t-aml) ili aml s миелодисплазией promjene (aml-МРЦ).
gefitinib mylan
mylan pharmaceuticals limited - gefitinib - karcinom, ne-malih stanica pluća - antineoplastic agents, protein kinase inhibitors - gefitinib mylan u određenom u monoterapiji za liječenje odraslih bolesnika s lokalno-uobičajena ili metastatskih немелкоклеточным raka pluća (НМРЛ) koja aktivira mutacije РЭФР‑tk.
gefitinib zentiva 250 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - gefitinib - filmom obložena tableta - 250 mg - urbroj: jedna tableta sadrži 250 mg gefitiniba
gefitinib pliva 250 mg filmom obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - gefitinib - filmom obložena tableta - 250 mg - urbroj: jedna filmom obložena tableta sadrži 250 mg gefitiniba
gefitinib sandoz 250 mg filmom obložene tablete
sandoz d.o.o., maksimirska 120, zagreb, hrvatska - gefitinib - filmom obložena tableta - 250 mg - urbroj: svaka tableta sadrži 250 mg gefitiniba
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastična sredstva - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
phrompo 250 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - gefitinib - filmom obložena tableta - 250 mg - urbroj: jedna tableta sadrži 250 mg gefitiniba
gefitinib sandoz 250 mg/1 tableta filmom obložena tableta
sandoz d.o.o. - gefitinib - filmom obložena tableta - 250 mg/1 tableta - 1 filmom obložena tableta sadrži: 250 mg gefitiniba
zelboraf 240 mg/1 tableta film tableta
roche d.o.o.roche ltd. - vemurafenib - film tableta - 240 mg/1 tableta - 1 film tableta sadrži: 240 mg vemurafeniba
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastična sredstva - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.